Matrix Laboratories, an Indian subsidiary of Mylan Inc has received tentative approval from the US health regulator for its new drug application for generic Lamivudine, Tenofovir Disoproxil Fumarate tablets. These drugs are used for treatment of AIDS/HIV. The product will be eligible for purchase outside the US in certain developing countries.
The company has received approval for the above tablets in the strengths of 300 mg co-packaged with Nevirapine tablets in the strength of 200 mg which is an important product developed by it. The tentative approval from the US Food and Drug Administration (USFDA) is through the President's Emergency Plan for AIDS Relief (PEPFAR).
The company also offers contract research and development services for earlier stages of development and contract manufacturing for projects that have advanced further into development and are being considered for commercial manufacturing.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.20 |
| Dr. Reddys Lab | 1209.85 |
| Cipla | 1224.00 |
| Zydus Lifesciences | 924.65 |
| Lupin | 2288.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: